News & Articles
Announcements, discoveries, and leadership in the field.
-
Senda Biosciences Appoints Luke O’Neill, Ph.D., as Chief Scientific OfficerSenda Biosciences
-
Senda Biosciences Appoints MIT Institute Professor Paula Hammond, Ph.D., to Its Board of DirectorsSenda Biosciences
-
Senda Biosciences Bolsters Executive Leadership TeamSenda Biosciences
-
Flagship startup Senda Biosciences raises $123 million for mRNA medicinesThe Boston Globe
-
Two years post-merger, Flagship’s Senda refines pipeline and replenishes the bankEndpoints News
-
Investors Senda message with $123M to back mystery pipeline from Flagship's reinvented biotechFierce Biotech
-
Senda Biosciences Announces Close of $123 Million Series C FinancingSenda Biosciences
-
Senda Biosciences Appoints Stuart Milstein, Ph.D., as SVP and Head of Platform BiologySenda Biosciences
-
Fierce Biotech Names Senda Biosciences a 2021 "Fierce 15" CompanyFierce Biotech
-
Senda Biosciences Strengthens Leadership Team with Key Management HiresSenda Biosciences